Biologics for Ankylosing Spondylitis Treatment: Types, Benefits, Risks

The Consumer’s Guide to Biologics for Ankylosing Spondylitis

Everything you need to know about these targeted systemic medications for ankylosing spondylitis (AS).
If your current ankylosing spondylitis (AS) treatment is not working well enough, or if your symptoms are limiting and interfering with your quality of life, you may want to consider biologics, a class of drugs that help reduce the inflammation that causes AS symptoms and leads to joint damage.

Understanding how biologics work and their benefits and risks will help you have a productive conversation with your healthcare provider when deciding whether these medications are right for you and how to work them into your treatment plan.

How Biologics Work for Ankylosing Spondylitis

Unlike synthetic medications such as nonsteroidal anti-inflammatory drugs (NSAIDs), biologics are created using living cells similar to molecules in your immune system.

Biologics are very large, complex molecules made from genetically engineered proteins designed to target inflammation, treat symptoms, and slow disease progression in AS.

How Biologics Work for Ankylosing Spondylitis

How Biologics Work for Ankylosing Spondylitis

Understanding Ankylosing Spondylitis: A Type of Inflammatory Arthritis

Ankylosing spondylitis is an inflammatory form of arthritis that primarily affects your spine.

If you have AS, your immune system, which normally protects your body from threats like viruses and bacteria, becomes overactive. This creates excess inflammation in the joints of your spine.

The inflammation can result in symptoms like pain and stiffness that can eventually make movement difficult, as the vertebrae (the bones in your spine) fuse together. This also makes you more vulnerable to fractures.

The exact cause of this overactive immune response is unknown, but a gene called HLA-B27 may play a role. HLA-B27 is part of a family of genes that helps the immune system tell the difference between germs and your body’s own cells.

Many people with ankylosing spondylitis have the HLA-B27 gene, but not everyone with the gene develops AS. An environmental trigger, such as an illness or bacterial infection, may activate the AS immune response.

How Biologics Target Ankylosing Spondylitis Inflammation

Biologics are a type of disease-modifying antirheumatic drug (DMARD). This means that in addition to relieving symptoms of AS, they also help block inflammation before it even starts. Unlike traditional DMARDs, which suppress the immune system on a broad level, biologics target specific molecules that play a role in triggering inflammation.

7 Essential Facts About Biologics for Ankylosing Spondylitis

Here’s what you need to know before deciding if a biologic is right for you.

Is It Time to Try a Biologic to Treat Ankylosing Spondylitis?

If you’re struggling to manage your AS symptoms, remember that you have options. Your rheumatologist can help you find a treatment — or combination of treatments — that meets your particular needs.

NSAIDs are often the first medication that doctors prescribe to treat AS. These drugs, which include over-the-counter and prescription options, help ease symptoms such as pain and stiffness.

If NSAIDs aren’t providing enough relief, you may be a candidate for a biologic.

“If symptoms are limiting and interfering with your daily activities, especially in the morning and [lasting longer] than 30 minutes, or if you find it difficult to sleep comfortably during the night and wake up due to pain, then it would be reasonable to discuss with your rheumatologist the need to be on biologics,” says Dr. Alkhatib.

Your exact treatment plan will depend on a number of factors, including your disease severity, personal preferences, medical history, and overall health.

A Rheumatologist Answers Your Questions About Biologics

Alkhatib answers the most common questions he hears from patients.

Steps for Self-Reflection

next-steps-922x338

Before your next appointment, reflect on these questions, which your doctor might ask about your treatment plan.

  • Are you satisfied with your current ankylosing spondylitis treatment?
  • Has it improved your pain and other ankylosing spondylitis symptoms as well as you had hoped?
  • How often do you have to cancel plans or adjust activities because of ankylosing spondylitis?
  • Are you downplaying your symptoms — or their impact on your quality of life — to your doctor?
  • Are you following your treatment regimen as prescribed?
  • Have you tried other treatment options yet?

Conversation Starters for Talking to Your Doctor

conversation-starters-for-talking-to-your-doctor-922x338

If you decide it’s time to discuss a potential treatment change with your doctor, jot down some questions you’d like to ask. Here are a few conversation starters that you can save to your phone and bring to your next doctor’s appointment.

  • What can I do to improve my pain and stiffness?
  • Am I a good candidate for biologics?
  • Which medication are you prescribing for me and why?
  • What results do you expect?
  • How long should I use this medication before monitoring the progress? 

The Takeaway

  • Biologics are a type of disease-modifying antirheumatic drug; they work by targeting some aspects of your immune system, relieving inflammation and associated symptoms of ankylosing spondylitis.
  • Biologics can be a good treatment option for AS if other therapies haven’t worked or if your symptoms limit you and interfere with your quality of life.
  • It’s important to discuss options with your managing physician or rheumatologist to decide on the best treatment course for your condition.

Additional reporting by Debra Fulghum Bruce, PhD, and Erin Coakley.

Resources We Trust

EDITORIAL SOURCES
Everyday Health follows strict sourcing guidelines to ensure the accuracy of its content, outlined in our editorial policy. We use only trustworthy sources, including peer-reviewed studies, board-certified medical experts, patients with lived experience, and information from top institutions.
Resources
  1. Biologic Therapy. National Axial Spondyloarthritis Society.
  2. A Guide to Biologic Therapy. National Ankylosing Spondyloarthritis Society. November 2018.
  3. Ankylosing Spondylitis. MedlinePlus. March 23, 2023.
  4. Mauro D et al. Ankylosing Spondylitis: an Autoimmune or Autoinflammatory Disease? Nature Reviews Rheumatology. July 2021.
  5. Overview of Ankylosing Spondylitis. Spondylitis Association of America.
  6. Biologics. Arthritis Foundation. September 3, 2022.
Additional Sources
  • Medications Used to Treat Ankylosing Spondylitis and Related Diseases. Spondylitis Association of America.
  • Savin E et al. Biologic Treatment Modification Efficacy in Concurrent Inflammatory Bowel Disease and Ankylosing Spondylitis: A Retrospective Cohort Study at a Single Tertiary Center. Journal of Clinical Medicine. November 17, 2023.
  • Zaki A et al. Biologics in Non-Infectious Uveitis: Past, Present, and Future. Annals of Eye ScienceJune 15, 2021.
  • Atzeni F et al. Cardiovascular Risk in Ankylosing Spondylitis and the Effect of anti-TNF Drugs: A Narrative Review. Expert Opinion on Biological Therapy. December 17, 2019.
  • Ankylosing Spondylitis Medications. GoodRx.
beth-biggee-bio

Beth Biggee, MD

Medical Reviewer

Beth Biggee, MD, is medical director and an integrative rheumatologist at Rheumission, a virtual integrative rheumatology practice for people residing in California and Pennsylvania. This first-of-its-kind company offers whole person autoimmune care by a team of integrative rheumatologists, lifestyle medicine practitioners, autoimmune dietitians, psychologists, and care coordinators.

Dr. Biggee also works as a healthcare wellness consultant for Synergy Wellness Center in Hudson, Massachusetts. Teamed with Synergy, she provides in-person lifestyle medicine and holistic consults, and contributes to employee workplace wellness programs. She has over 20 years of experience in rheumatology and holds board certifications in rheumatology and integrative and lifestyle medicine. Dr. Biggee brings a human-centered approach to wellness rather than focusing solely on diseases.

Dr. Biggee graduated cum laude with a bachelor's degree from Canisius College, and graduated magna cum laude and as valedictorian from SUNY Health Science Center at Syracuse Medical School. She completed her internship and residency in internal medicine at Yale New Haven Hospital, completed her fellowship in rheumatology at Tufts–New England Medical Center, and completed training in integrative rheumatology at the University of Arizona Andrew Weil Center for Integrative Medicine. Following her training, she attained board certification in rheumatology and internal medicine through the American Board of Internal Medicine, attained board certification in integrative medicine through the American Board of Physician Specialties, and attained accreditation as a certified lifestyle medicine physician through the American College of Lifestyle Medicine. She is certified in Helms auricular acupuncture and is currently completing coursework for the Aloha Ayurveda integrative medicine course for physicians.

In prior roles, Dr. Biggee taught as an assistant clinical professor of medicine at Mary Imogene Bassett Hospital (an affiliate of Columbia University). She was also clinical associate of medicine at Tufts University School of Medicine and instructed "introduction to clinical medicine" for medical students at Tufts. She was preceptor for the Lawrence General Hospital Family Medicine Residency.

Dr. Biggee has published in Annals of Rheumatic Diseases, Arthritis in Rheumatism, Current Opinions in Rheumatology, Journal for Musculoskeletal Medicine, Medicine and Health Rhode Island, and Field Guide to Internal Medicine.

Ana Sandoiu

Author

Ana is a freelance medical copywriter, editor, and health journalist with a decade of experience in content creation. She loves to dive deep into the research and emerge with engaging and informative content everyone can understand. Her strength is combining scientific rigor with empathy and sensitivity, using conscious, people-first language without compromising accuracy.

Previously, she worked as a news editor for Medical News Today and Healthline Media. Her work as a health journalist has reached millions of readers, and her in-depth reporting has been cited in multiple peer-reviewed journals. As a medical copywriter, Ana has worked with award-winning digital agencies to implement marketing strategies for high-profile stakeholders. She’s passionate about health equity journalism, having conceived, written, and edited features that expose health disparities related to race, gender, and other social determinants of health.

Outside of work, she loves dancing, taking analog photos, and binge-watching all the RuPaul’s Drag Race franchises.